查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1863151

全球脑部影像诊断设备市场：洞察、竞争格局及市场预测（至2032年）

Brain Imaging Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

脑部影像诊断设备市场摘要

  • 全球脑部影像诊断设备市场预计将从 2024 年的 50.9171 亿美元成长到 2032 年的 77.7985 亿美元，反映出强劲且持续的成长。
  • 全球脑部影像设备市场在 2025 年至 2032 年的预测期内将以 5.50% 的复合年增长率成长。
  • 全球脑部影像诊断设备市场的发展动力来自神经系统疾病的日益普遍、技术进步（尤其是人工智慧和机器学习的融合）以及主要市场参与者不断增加的产品开发活动，包括 MRI、CT 和 PET 技术的创新。
  • 脑造影诊断设备市场的主要企业包括西门子医疗私人有限公司、通用电气医疗集团、皇家飞利浦公司、佳能医疗系统株式会社、日立高新技术公司、富士胶片控股株式会社、岛津公司、Esaote SPA、Mediso Ltd.、三星电子有限公司、民方医疗系统有限公司、上海影联医疗股份有限公司、Voxelidate Limiteds InMRations、上海民方医疗系统有限公司、上海影联医疗有限公司Solutions、珀金埃尔默、金斯威生物科技有限公司、席勒、东软医疗系统有限公司、时代医疗控股和科宁医疗。
  • 由于神经系统疾病的高发生率、强大的研发投入、先进的医疗基础设施以及主要医疗设备公司不断进行的技术创新，北美脑影像诊断设备市场在全球占据主导地位。
  • 根据产品类型，预计到 2024 年，设备类产品将占据最大的市场份额。

脑部影像诊断设备市场的成长要素

  • 神经系统疾病的日益普遍正推动脑影像市场的快速扩张：阿兹海默症、帕金森氏症、癫痫、中风、多发性硬化症和脑肿瘤等神经系统疾病在全球范围内呈上升趋势，这主要是由于人口老龄化以及肥胖、压力和心血管疾病等生活方式相关的风险因素所致。由于这些疾病需要精准诊断和持续监测，MRI、CT 和 PET 等脑部影像设备变得至关重要。例如，MRI 有助于检测阿兹海默症的脑萎缩，而 CT 和 PET 对于检测中风和评估肿瘤至关重要。不断增长的患者群体直接推动了临床和研究领域对先进脑部影像技术的需求。
  • 人工智慧和机器学习等技术的进步将推动脑成像设备的普及：人工智慧 (AI) 和机器学习 (ML) 正在透过提高影像品质、增强诊断准确性和缩短报告时间来变革脑成像。例如，整合人工智慧的磁振造影 (MRI) 和正子断层扫描 (PET) 系统现在能够识别与阿兹海默症相关的淀粉样蛋白和Tau沉积。此外，人工智慧赋能的工作流程自动化可以减轻临床医生的工作量，提高效率，并扩大诊断影像服务的覆盖范围，尤其是在大型医院和远端影像平台。
  • 主要企业加大产品研发力度：领先的医疗设备公司和新兴企业正大力投资开发创新脑造影解决方案。这些解决方案包括用于照护现场的可携式核磁共振造影系统、用于更全面成像诊断的PET/MRI混合平台，以及具有低剂量辐射和快速扫描功能的先进CT系统。飞利浦、西门子医疗、GE医疗和Hyperfine等公司正引领着下一代设备的研发，这些设备配备了人工智慧、增强硬体和专用的神经影像应用程式。持续的产品发布和监管核准不仅拓展了临床效用，也提高了医院、诊断中心和研究机构的采用率，从而推动了整体市场成长。

脑部影像诊断设备市场报告细分

本研究报告全面概​​述了全球脑部影像诊断设备市场，重点阐述了关键趋势、市场驱动因素、挑战和机会。报告按产品类型、应用、最终用户和地区对脑成像诊断设备市场进行了深入分析，并深入剖析了北美、欧洲和亚太等主要市场的竞争格局、监管环境和市场动态。报告详细介绍了行业领导者的概况和近期产品开发情况，为企业识别市场潜力、制定战略规划以及把握快速增长的脑成像诊断设备市场中的新机会提供了重要数据。

脑部影像设备是用于可视化大脑结构和功能的先进诊断工具，在检测和监测阿兹海默症、中风、癫痫、帕金森氏症和脑肿瘤等神经系统疾病方面发挥关键作用。主要影像方式包括磁振造影（MRI）、电脑断层扫描（CT）、正子断层扫描（PET）、脑电图（EEG）和脑磁图（MEG），每种方式都提供独特的结构、功能和代谢成像能力。受神经系统疾病盛行率上升、人口老化以及人工智慧影像、可携式MRI系统和PET/MRI混合平台等持续技术进步的推动，脑影像市场正经历快速成长。这些技术创新正在提高诊断准确性，实现早期检测，并扩大已开发经济体和新兴经济体医疗保健系统获得高品质神经影像服务的途径。

脑造影设备市场正因多种因素而稳定成长。阿兹海默症、帕金森氏症、中风、癫痫和脑肿瘤等神经系统疾病的日益普遍，催生了对能够实现精准诊断和有效治疗方案製定的先进影像解决方案的强劲需求。全球人口老化和生活方式相关的风险因素进一步加剧了这些疾病的发生率。技术进步，特别是人工智慧和机器学习在磁振造影（MRI）、电脑断层扫描（CT）和正子断层扫描（PET）系统中的应用，正在提升影像诊断的准确性、速度和诊断能力，从而改善临床疗效。此外，主要企业正加大产品研发力度，推出可携式MRI系统、PET/MRI混合平台和人工智慧驱动的影像软体等创新设备，以拓展临床应用范围并提高其可及性。这些因素，加上人们对早期诊断意识的不断提高和医疗保健投资的持续成长，将继续推动全球脑部影像设备市场的成长。

由于脑部肿瘤、中风、阿兹海默症、帕金森氏症和癫痫等神经系统疾病的盛行率不断上升，脑部影像诊断设备市场正经历显着成长。人口老化和生活方式相关的风险因素共同推动了这一趋势。技术进步，特别是人工智慧 (AI) 和机器学习 (ML) 的融合，进一步提高了成像精度、诊断速度和临床决策能力，从而能够实现更早期的检测和更个性化的治疗策略。同时，领先企业在磁振造影 (MRI)、电脑断层扫描 (CT) 和正子断层扫描 (PET) 技术方面的持续产品研发和创新，正在拓宽应用范围，提高整体效率，并支持市场扩张。

根据DelveInsight统计，全球约有5,050万人患有癫痫，其中近80%居住在中低收入国家。脑部影像检查，例如磁振造影（MRI）、电脑断层扫描（CT）和正子断层扫描（PET），在检测可能导致癫痫发作的结构异常、病变、肿瘤和疤痕方面发挥着至关重要的作用。因此，对先进影像技术的日益依赖已成为全球市场成长的主要驱动力。同样，分析师估计全球约有2100万人患有脑出血（ICH）。在这种情况下，快速且准确的影像学检查对于确定出血的位置、大小和原因，指导紧急内科和外科干预，以及区分脑出血和缺血性中风至关重要。 CT和MRI仍然是急诊医学中监测血肿发展和治疗反应的重要工具。

人工智慧和机器学习的融合正在透过提高诊断准确性和简化工作流程来加速市场发展。 Hyperfine 的 Swoop®可携式磁振造影系统、飞利浦的 Smart Quant Neuro 3D 系统FUJIFILM的 ECHELON Synergy 系统等公司，都在将人工智慧功能整合到其磁共振成像 (MRI)、电脑断层扫描 (CT) 和正子断层扫描 (PET) 平台中，以优化影像品质并实现自动化报告。 2024 年 12 月，佳能医疗系统美国公司推出了 INSTINX 和 Vitrea 等工具，进一步扩展了其人工智慧赋能的 CT 产品组合，旨在加速诊断流程并提高临床准确性。该产品组合还包括一些专注于临床的软体包，例如用于脑出血 (ICH)、大血管闭塞 (LVO) 和 CT 脑灌注成像的中风 CT 软体包。

因此，疾病流行率上升、对准确诊断的需求增加以及技术快速创新等因素预计将在预测期内（即 2025-2032 年）推动全球脑部影像诊断设备市场强劲成长。

儘管需求不断成长，但脑部影像诊断设备市场仍面临许多限制因素，可能阻碍其扩张。其中一个主要挑战是设备及持续维护成本高昂，因为诸如磁振造影（MRI）、电脑断层扫描（CT）和正子断层扫描（PET）等先进影像处理设备需要大量的资金投入、专门的基础设施和持续的维护。这对于规模较小的医院和诊断中心，尤其是在发展中地区，构成了一道障碍。另一个令人担忧的问题是CT和PET等检查方式带来的辐射暴露风险，这会对病患安全构成威胁，特别是对于需要反覆检查的弱势族群。这些因素不仅影响购买决策，还会引发监管审查，限制设备的广泛应用，进而影响整体市场成长。

脑部影像诊断设备市场細項分析

脑部影像诊断设备市场按产品类型、应用、最终用户和地区划分

脑部影像诊断设备市场区域分析

北美脑部影像诊断设备市场趋势

以美国为首的北美地区将主导全球脑部影像诊断设备市场，到2024年将占据约41%的市场。北美脑部影像诊断设备市场正稳步扩张，这主要得益于神经系统疾病的高发生率、强劲的研发投入、先进的医疗基础设施以及主要医疗设备公司持续不断的技术创新。此外，人们对早期诊断意识的不断提高以及尖端成像技术的广泛应用进一步巩固了该地区的领先地位，确保主导地位。

根据DelveInsight的分析，美国每年报告的阿兹海默症超过750万人，预计到2050年，这个数字将几乎翻一番，达到1,300万人。大约每九名65岁以上的老年人中就有一人受到影响，女性的风险更高。脑部影像在检测老年痴呆症相关变化方面发挥关键作用，例如海马萎缩、皮质变薄以及淀粉样蛋白和Tau蛋白等有害蛋白质的累积。磁振造影（MRI）和正子断层扫描（PET）等影像技术，特别是淀粉样蛋白PET和TauPET，被广泛应用于临床和研究领域，以识别神经神经退化的早期标记、追踪疾病进展并评估治疗效果。

此外，脑肿瘤发生率的上升进一步推动了对先进成像技术的需求。截至2023年，美国约有100万人罹患脑肿瘤。无论是恶性肿瘤还是良性肿瘤，都需要高解析度影像来确定其大小、位置以及与周围脑组织的关係，这对于手术计划、放射线治疗和持续监测至关重要。磁振造影（MRI）仍然是肿瘤检测的黄金标准，它能提供出色的软组织对比度，从而可以精确地勾勒出肿瘤边界并评估其潜在的侵袭性。

除了疾病流行之外，北美市场也受益于快速的技术创新和频繁的产品发布。例如，在2024年12月的北美放射学会（RSNA）年会上，飞利浦在北美推出了其配备人工智慧的CT 5300系统。该系统整合了先进的硬体和人工智慧主导的智慧工作流程解决方案，旨在提高诊断信心、缩短扫描时间并提升高品质影像的获取便利性。其自动患者定位、高精度脑部和心臟成像以及优化的辐射剂量等功能，使其特别适用于神经心血管应用和低剂量筛检项目。

欧洲脑部影像诊断设备市场趋势

由于阿兹海默症、失智症、中风和癫痫等神经系统疾病病例不断增加，欧洲脑部造影设备市场正经历强劲成长。这些疾病在该地区老龄化人口中日益普遍。推动市场发展的关键趋势是将人工智慧整合到磁振造影（MRI）、电脑断层扫描（CT）、正子断层扫描（PET）和脑电图（EEG）系统中，这将提高诊断准确性并简化临床工作流程。

此外，领先的医疗技术公司、研究机构和大学之间的合作正在加速PET/MRI和低场可携式MRI等混合成像技术的应用。该地区云端基础成像平台和远端影像服务的应用也日益普及，从而改善了专业诊断服务的可近性，尤其是在医疗资源匮乏的地区。此外，欧盟「地平线欧洲」等计画对神经科学研究的投入不断增加，刺激了创新；同时，对人工智慧医疗设备的监管支持也为新兴企业和数位医疗公司创造了机会。

因此，欧洲脑造影设备市场呈现稳定成长的态势，这得益于人口老化、先进的医疗保健系统以及对创新诊断和影像解决方案的重视。

亚太地区脑部影像诊断设备市场趋势

亚太地区脑部影像设备市场正快速扩张，在2025年至2032年的预测期内，预计将以6.87%的强劲复合年增长率成长。推动这一成长的主要因素包括神经系统疾病盛行率的上升、医疗保健投资的增加以及先进诊断技术的快速普及。中国、日本、印度和韩国等国家已成为主要贡献者，其不断完善的医院基础设施、政府推行的早期诊断倡议以及日益增强的脑健康意识都促进了市场需求。日本持续引领技术创新，大力推广高端MRI和PET系统；而中国则快速扩大国内生产能力，减少对进口的依赖。在印度，中风和失智症负担的加重，以及城市地区先进影像技术的普及，都创造了巨大的商机。此外，人工智慧成像解决方案、远端成像以及可携式设备的整合应用在全部区域日益普及，使得神经影像学在农村地区也更容易获得。全球设备製造商与当地企业之间的战略伙伴关係、有利的监管改革以及医疗旅游的支持性趋势，正在进一步塑造亚太市场格局。

以下列出了脑部影像诊断设备市场的主要企业，它们总合占据最大的市场份额，并引领着产业趋势：

  • Siemens Healthcare Private Limited
  • GE HealthCare
  • Koninklijke Philips NV
  • CANON MEDICAL SYSTEMS CORPORATION
  • Hitachi High-Tech Corporation
  • Fujifilm Holdings Corporation
  • Shimadzu Corporation
  • Esaote SPA
  • Mediso Ltd.
  • Samsung Electronics Co. Ltd
  • MinFound Medical Systems Co., Ltd.
  • Shanghai United Imaging Healthcare Co., Ltd.
  • Voxelgrids Innovations Private Limited
  • MR Solutions
  • PerkinElmer
  • Kindsway Biotech Co., Ltd.
  • SCHILLER
  • Neusoft Medical Systems Co., Ltd.
  • Time Medical Holding
  • Koning Health

脑影像设备市场的竞争格局高度集中，全球主要医疗技术公司、影像处理专家和新兴创新者专注于人工智慧主导的解决方案。西门子医疗、通用电气医疗、飞利浦医疗和佳能医疗系统等现有企业凭藉其丰富的产品系列和强大的全球分销网络，在磁振造影（MRI）、电脑断层扫描（CT）和正子断层扫描（PET）影像领域占据市场主导地位。同时，一些专注于特定领域的企业和新兴企业也在可携式脑电图（EEG）、脑磁图（MEG）和功能成像设备以及透过机器学习和资料整合提高诊断准确性的软体方面做出贡献。随着各公司寻求拓展神经病学、肿瘤学和精神病学领域的临床应用，策略联盟、併购和研究合作正日益影响市场格局。此外，混合成像系统和无创技术的发展，以及新兴国家日益增长的需求，加剧了市场竞争，同时也为技术差异化和市场扩张铺平了道路。

脑部影像设备市场的最新发展

  • Hyperfine, Inc. 是一家开创性的医疗技术公司，该公司于 2025 年 9 月推出了 Swoop® 系统，这是首个获得 FDA 批准的用于脑部成像的 AI 驱动可携式MRI 系统，彻底改变了脑成像技术。该公司宣布，其 Optive AI™ 软体已获得 CE 标誌和英国合格评定 (UKCA)核准。
  • 2025年3月，Hyperfine与NVIDIA合作，增强其Swoop可携式磁振造影系统的人工智慧功能。 Swoop是全球首款获得FDA核准的可携式磁振造影设备，代表了便利神经影像技术的突破性进展。

脑部影像诊断设备市场细分

  • 按产品类型分類的脑部影像诊断设备发展趋势
  • 装置
  • 磁振造影造影（MRI）
  • 电脑断层扫描（CT/SPECT）
  • 正子断层扫描（PET）
  • 其他的
  • 配件和耗材
  • 按便携性分類的脑部影像诊断设备发展趋势
  • 固定类型
  • 可携式的
  • 按应用领域分類的脑部影像诊断设备发展趋势
  • 中风
  • 脑肿瘤
  • 癫痫
  • 其他的
  • 脑部影像诊断设备终端用户趋势
  • 医院
  • 诊断影像中心
  • 门诊手术中心
  • 其他的
  • 脑部影像诊断设备的区域趋势
  • 北美脑部影像诊断设备市场
  • 美国脑部影像诊断设备市场
  • 加拿大脑部影像诊断设备市场
  • 墨西哥脑部影像诊断设备市场
  • 欧洲脑部影像诊断设备市场
  • 英国脑部影像设备市场
  • 德国脑部影像诊断设备市场
  • 法国脑部影像诊断设备市场
  • 义大利脑部影像诊断设备市场
  • 西班牙脑部影像诊断设备市场
  • 其他欧洲脑部影像诊断设备市场
  • 亚太地区脑部影像诊断设备市场
  • 中国脑部影像设备市场
  • 日本脑部影像诊断设备市场
  • 印度脑部影像诊断设备市场
  • 澳洲脑部影像诊断设备市场
  • 韩国脑部影像诊断设备市场
  • 亚太地区其他脑部影像诊断设备市场
  • 世界其他地区脑部影像诊断设备市场
  • 南美洲脑部影像诊断设备市场
  • 中东脑部影像诊断设备市场
  • 非洲脑部影像诊断设备市场

影响分析

人工智慧驱动的创新正在改变脑部影像市场，提高诊断准确率，简化工作流程，并催生新的临床应用。整合到磁振造影 (MRI)、电脑断层扫描 (CT)、正子断层扫描 (PET)、脑电图 (EEG) 和脑磁图 (MEG) 系统中的先进演算法，如今能够检测细微异常，自动解读影像，并为中风、阿兹海默症、癫痫和脑肿瘤等神经系统疾病提供预测性见解。这些工具能够减少诊断错误，加快决策速度，并支持早期疗育策略。此外，人工智慧主导的平台正越来越多地应用于远端放射学和云端基础成像解决方案，扩大了高品质神经影像的覆盖范围，即使在服务不足的地区也能受益。除了诊断之外，人工智慧在研究和药物开发中也发挥关键作用，能够精确绘製脑活动图谱，监测治疗效果，并支持临床试验。将深度学习和机器学习模型与脑部影像技术结合，正推动神经系统疾病诊疗产业朝着更个人化、数据主导的方向发展。

美国关税对脑影像设备市场的影响分析：

美国对包括脑部影像系统（如MRI、CT和PET扫描仪）组件在内的医疗设备征收关税，正对市场产生显着影响。许多脑部影像设备依赖专用组件、先进半导体和高精度电子元件，这些元件通常来自海外，尤其是中国、日本和欧盟。对这些进口产品征收关税会增加製造成本和采购成本，最终推高脑部造影系统的整体价格。这不仅迫使製造商自行承担或转嫁这些额外成本，还会影响医院、诊断中心和研究机构的采购决策，尤其是预算有限的小型机构。此外，设备价格上涨可能会减缓美国对下一代影像处理技术的采用，并加剧大型都市区医院与小型或农村医疗机构之间的医疗资源取得差距。同时，这些关税也可能刺激国内创新和在地采购策略，因为企业会寻求减少对进口组件的依赖，从长远来看，这可能会重塑竞争格局。

目录

第一章 脑部影像诊断设备市场报告概述

  • 调查范围
  • 市场区隔
  • 市场假设

第二章 脑部影像诊断设备市场执行摘要

  • 市场概览

第三章：脑部影像诊断设备市场关键因素分析

  • 市场驱动因素
    • 神经系统疾病盛行率不断上升
    • 人工智慧和机器学习的融合等技术进步
    • 主要参与企业加大了产品开发活动。
  • 市场限制与挑战
    • 高昂的设备和维护成本
    • 辐射暴露风险较高
  • 市场机会
    • 可携式成像设备和照护现场技术的使用日益增加。

第四章 影响分析

  • 人工智慧驱动的创新和应用
  • 美国关税的影响分析

第五章 监理分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第六章：脑部影像诊断设备市场：波特五力分析

第七章 脑部影像诊断设备市场评估

  • 依产品类型
    • 装置
    • 配件和耗材
  • 透过便携性
    • 静止的
    • 可携式的
  • 透过使用
    • 中风
    • 脑肿瘤
    • 癫痫
    • 其他的
  • 最终用户
    • 医院
    • 诊断影像中心
    • 门诊手术中心
  • 地区
    • 北美洲
    • 欧洲
    • 亚太地区
    • 其他地区

第八章 竞争情势

第九章Start-Ups资金筹措与投资趋势

第十章 脑部影像诊断设备市场中的公司与产品概况

  • Siemens Healthcare Private Limited
  • GE Healthcare
  • Koninklijke Philips NV
  • CANON MEDICAL SYSTEMS CORPORATION
  • Hitachi High-Tech Corporation
  • Fujifilm Holdings Corporation
  • Shimadzu Corporation
  • Esaote SPA
  • Mediso Ltd.
  • Samsung Electronics Co. Ltd
  • MinFound Medical Systems Co., Ltd.
  • Shanghai United Imaging Healthcare Co., Ltd.
  • Voxelgrids Innovations Private Limited
  • MR Solutions
  • PerkinElmer
  • Kindsway Biotech Co., Ltd.
  • SCHILLER
  • Neusoft Medical Systems Co., Ltd.
  • Time Medical Holding
  • Koning Health

第十一章：KOL视角

第十二章计划方法

第十三章：关于 DelveInsight

第十四章 免责声明和联络我们

Product Code: DIMDCL0842

Brain Imaging Devices Market Summary

  • The global brain imaging devices market is expected to increase from USD 5,091.71 million in 2024 to USD 7,779.85 million by 2032, reflecting strong and sustained growth.
  • The global brain imaging devices market is growing at a CAGR of 5.50% during the forecast period from 2025 to 2032.
  • The global brain imaging devices market is driven by the rising prevalence of neurological disorders, technological advancements, especially AI and ML integration, and increasing product development activities by key market players, including innovations in MRI, CT, and PET technologies.
  • The leading companies operating in the brain imaging devices market include Siemens Healthcare Private Limited, GE HealthCare, Koninklijke Philips N.V., CANON MEDICAL SYSTEMS CORPORATION, Hitachi High-Tech Corporation, Fujifilm Holdings Corporation, Shimadzu Corporation, Esaote SPA, Mediso Ltd., Samsung Electronics Co. Ltd, MinFound Medical Systems Co., Ltd., Shanghai United Imaging Healthcare Co., Ltd., Voxelgrids Innovations Private Limited, MR Solutions, PerkinElmer, Kindsway Biotech Co., Ltd., SCHILLER, Neusoft Medical Systems Co., Ltd., Time Medical Holding, Koning Health, and others.
  • The North American brain imaging devices market is a dominant force globally, driven by the high prevalence of neurological disorders, strong R&D investment, advanced healthcare infrastructure, and continuous innovation by leading medical device companies.
  • In the product type segment of the brain imaging devices market, the devices category is estimated to account for the largest market share in 2024.

Factors Contributing to the Growth of the Brain Imaging Devices Market

  • The rising prevalence of neurological disorders is leading to a surge in the brain imaging devices market: Neurological conditions such as Alzheimer's disease, Parkinson's disease, epilepsy, stroke, multiple sclerosis, and brain tumors are increasing globally, primarily due to aging populations and lifestyle-related risk factors like obesity, stress, and cardiovascular disease. These disorders require accurate diagnosis and continuous monitoring, making brain imaging devices such as MRI, CT, and PET scanners essential. For instance, MRI helps detect brain shrinkage in Alzheimer's, while CT and PET are crucial for stroke detection and tumor evaluation. The growing patient pool directly drives the demand for advanced brain imaging technologies in both clinical and research settings.
  • Technological advancements such as the integration of AI and ML lead to higher adoption of brain imaging devices: Artificial intelligence (AI) and machine learning (ML) are transforming brain imaging by improving image quality, enhancing diagnostic precision, and reducing reporting time. AI-powered tools can detect subtle abnormalities, automate image segmentation, and even predict disease progression, supporting earlier and more personalized treatment decisions. For example, AI-integrated MRI and PET systems are now capable of identifying amyloid and tau protein deposits linked to Alzheimer's disease. Additionally, workflow automation enabled by AI reduces clinician workload, improves efficiency, and expands access to imaging services, particularly in high-volume hospitals and tele-radiology platforms.
  • Increase in product development activities among key players: Leading medical device companies and startups are heavily investing in the development of innovative brain imaging solutions. These include portable MRI devices for point-of-care diagnostics, hybrid PET/MRI platforms for more comprehensive imaging, and advanced CT systems with low-dose radiation and faster scanning capabilities. Companies like Philips, Siemens Healthineers, GE Healthcare, and Hyperfine are at the forefront of introducing next-generation devices equipped with AI, enhanced hardware, and specialized neuroimaging applications. Continuous product launches and regulatory approvals not only expand clinical utility but also increase adoption across hospitals, diagnostic centers, and research institutes, boosting overall market growth.

Brain Imaging Devices Market Report Segmentation

This brain imaging devices market report offers a comprehensive overview of the global Brain Imaging Devices market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation Brain Imaging Devices Market by Product Type (Devices [Magnetic Resonance Imaging (MRI), Computed Tomography (CT/SPECT), Positron Emission Tomography (PET), and Others] and Accessories & Consumables), Portability (Stationary and Portable), Application (Stroke, Brain Tumor, Epilepsy, and Others), End-User (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgery Centers, and Others), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing Brain Imaging Devices market.

Brain imaging devices are advanced diagnostic tools used to visualize the structure and function of the brain, playing a crucial role in detecting and monitoring neurological disorders such as Alzheimer's, stroke, epilepsy, Parkinson's disease, and brain tumors. Key modalities include MRI, CT, PET, EEG, and MEG, each offering unique capabilities for structural, functional, and metabolic imaging. The market is growing rapidly, fueled by rising neurological disease prevalence, an aging population, and continuous technological advancements such as AI-powered imaging, portable MRI systems, and hybrid PET/MRI platforms. These innovations are improving diagnostic accuracy, enabling early detection, and expanding access to high-quality neuroimaging across both developed and emerging healthcare systems.

The brain imaging devices market is witnessing steady growth, driven by multiple factors. The rising prevalence of neurological disorders such as Alzheimer's disease, Parkinson's disease, stroke, epilepsy, and brain tumors has created a strong demand for advanced imaging solutions that enable accurate diagnosis and effective treatment planning. An aging global population, coupled with lifestyle-related risk factors, is further contributing to the growing incidence of these conditions. Technological advancements, particularly the integration of artificial intelligence and machine learning into MRI, CT, and PET systems, are improving imaging accuracy, speed, and diagnostic capabilities, thereby enhancing clinical outcomes. In addition, leading market players are intensifying product development activities, introducing innovative devices such as portable MRI systems, hybrid PET/MRI platforms, and AI-driven imaging software to expand clinical applications and accessibility. These factors, combined with increasing awareness of early diagnosis and rising healthcare investments, continue to propel the growth of the brain imaging devices market worldwide.

What are the latest Brain Imaging Devices Market Dynamics and Trends?

The brain imaging devices market is experiencing significant growth, largely driven by the increasing prevalence of neurological disorders such as brain tumors, strokes, Alzheimer's disease, Parkinson's disease, and epilepsy. This trend is fueled by both aging demographics and lifestyle-related risk factors. Technological advancements, particularly the integration of artificial intelligence (AI) and machine learning (ML), are further enhancing imaging accuracy, diagnostic speed, and clinical decision-making, enabling earlier detection and more personalized treatment strategies. In parallel, continuous product development and innovation in MRI, CT, and PET technologies by leading players are broadening the scope of applications and improving overall efficiency, collectively propelling market expansion.

According to DelveInsight, around 50.5 million people worldwide are affected by epilepsy, with nearly 80% residing in low- and middle-income countries. Brain imaging modalities such as MRI, CT, and PET scans play a crucial role in detecting structural abnormalities, lesions, tumors, or scarring responsible for seizures. This growing reliance on advanced imaging to support accurate epilepsy diagnosis is emerging as a key driver of global market growth. Similarly, analysts estimate that nearly 21 million people globally are living with intracerebral hemorrhage (ICH). In such cases, rapid and precise imaging is essential to identify the location, size, and cause of bleeding, guide urgent medical or surgical interventions, and distinguish ICH from ischemic stroke. CT and MRI remain indispensable tools in emergency care for monitoring hematoma development and treatment response.

The integration of AI and ML is accelerating market momentum by refining diagnostic precision and streamlining workflows. Companies such as Hyperfine with its Swoop(R) Portable MRI, Philips with Smart Quant Neuro 3D, and Fujifilm with ECHELON Synergy are embedding AI capabilities into MRI, CT, and PET platforms to optimize image quality and automate reporting. In December 2024, Canon Medical Systems USA expanded its AI-enabled CT portfolio by launching tools such as INSTINX and Vitrea, designed to accelerate diagnostic processes and improve clinical accuracy. The portfolio also featured specialized clinical packages, including a Stroke CT Package with applications for intracerebral hemorrhage (ICH), large vessel occlusion (LVO), and CT brain perfusion.

Therefore, these factors, including rising disease prevalence, growing demand for precise diagnostics, and rapid technological innovation, are expected to drive strong growth in the global brain imaging devices market throughout the forecast period of 2025 to 2032.

Despite the growing demand, the brain imaging devices market faces several restraints that could hinder its expansion. One of the primary challenges is the high cost of equipment and ongoing maintenance, as advanced imaging modalities like MRI, CT, and PET scanners require significant capital investment, specialized infrastructure, and continuous servicing. This creates a barrier for smaller hospitals and diagnostic centers, particularly in developing regions. Another concern is the risk of radiation exposure associated with modalities such as CT and PET, which raises patient safety issues, especially for vulnerable groups requiring repeated scans. These factors not only influence purchasing decisions but also drive regulatory scrutiny and limit widespread adoption, thereby impacting overall market growth.

Brain Imaging Devices Market Segment Analysis

Brain Imaging Devices Market by Product Type (Devices [Magnetic Resonance Imaging (MRI), Computed Tomography (CT/SPECT), Positron Emission Tomography (PET), and Others] and Accessories & Consumables), Portability (Stationary and Portable), Application (Stroke, Brain Tumor, Epilepsy, and Others), End-User (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgery Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Brain Imaging Devices Market Regional Analysis

North America Brain Imaging Devices Market Trends

North America, led by the United States, dominates the global brain imaging devices market, accounting for approximately 41% of the total market share in 2024. The North American brain imaging devices market is expanding steadily, driven by the high prevalence of neurological disorders, strong R&D investments, advanced healthcare infrastructure, and continuous innovation from leading medical device companies. The region's dominance is further reinforced by growing awareness of early diagnosis and broad adoption of cutting-edge imaging technologies, securing its leading position in the global landscape.

According to DelveInsight analysis, more than 7.5 million people in the U.S. were living with Alzheimer's disease in the reported year, with the number projected to nearly double to 13 million by 2050. Approximately one in nine individuals aged 65 and above is affected, with women facing a higher risk. Brain imaging plays a vital role in detecting Alzheimer-related changes, such as hippocampal shrinkage, cortical thinning, and the accumulation of harmful proteins like amyloid and tau. Modalities such as magnetic resonance imaging (MRI) and positron emission tomography (PET), particularly amyloid PET and tau PET, are extensively used in clinical and research settings to identify early markers of neurodegeneration, track disease progression, and assess treatment efficacy.

In addition, the burden of brain tumors further highlights the critical need for advanced imaging technologies. As of 2023, nearly one million people in the U.S. were living with a brain tumor. Both malignant and benign tumors require high-resolution imaging to determine size, location, and relationship to surrounding brain structures, which is crucial for surgical planning, radiation therapy, and ongoing monitoring. MRI remains the gold standard for tumor detection, offering exceptional soft tissue contrast that enables accurate delineation of tumor boundaries and assessment of potential infiltration.

Beyond disease prevalence, the North American market benefits significantly from rapid technological innovation and frequent product launches. For instance, in December 2024 at RSNA, Philips introduced its AI-powered CT 5300 system in North America. The system integrates advanced hardware with AI-driven Smart Workflow solutions to enhance diagnostic confidence, reduce scan time, and improve accessibility to high-quality imaging. Features such as automated patient positioning, precise brain and cardiac imaging, and optimized radiation dosing make it particularly suitable for both neurological and cardiovascular applications, as well as low-dose screening programs.

Europe Brain Imaging Devices Market Trends

The Europe brain imaging devices market is witnessing strong growth driven by rising cases of neurological disorders such as Alzheimer's disease, dementia, stroke, and epilepsy, which are increasingly prevalent in the region's aging population. Governments and healthcare systems across Europe are investing heavily in early diagnosis and advanced neuroimaging infrastructure, supported by favorable reimbursement frameworks in countries like Germany, France, and the U.K. A major trend shaping the market is the integration of artificial intelligence into MRI, CT, PET, and EEG systems, which enhances diagnostic precision and streamlines clinical workflows.

In addition, collaborations between leading medtech companies, research institutes, and universities are accelerating the adoption of hybrid imaging technologies such as PET/MRI and low-field portable MRI solutions. The region is also seeing significant uptake of cloud-based imaging platforms and tele-radiology services, which improve access to specialized diagnostics, particularly in underserved areas. Furthermore, increased funding for neuroscience research under EU programs like Horizon Europe is driving innovation, while regulatory support for AI-based medical devices is creating opportunities for startups and digital health companies.

Hence, the Europe brain imaging devices market is characterized by steady growth, shaped by aging demographics, advanced healthcare systems, and a strong focus on innovative diagnostic and imaging solutions.

Asia-Pacific Brain Imaging Devices Market Trends

The Asia-Pacific brain imaging devices market is witnessing rapid expansion, reflecting a robust CAGR of 6.87% during the forecast period from 2025 to 2032, driven by the rising prevalence of neurological disorders, increasing healthcare investments, and rapid adoption of advanced diagnostic technologies. Countries such as China, Japan, India, and South Korea are emerging as key contributors, with expanding hospital infrastructure, government initiatives for early diagnosis, and growing awareness about brain health fueling demand. Japan continues to lead in technological innovation with strong adoption of high-end MRI and PET systems, while China is rapidly expanding its domestic manufacturing capabilities to reduce reliance on imports. In India, the increasing burden of stroke and dementia, coupled with improving access to advanced imaging modalities in urban centers, is creating significant opportunities. Additionally, the integration of AI-driven imaging solutions, tele-radiology, and portable devices is gaining traction across the region, making neuroimaging more accessible even in rural areas. Strategic partnerships between global device manufacturers and local players, along with favorable regulatory reforms and supportive medical tourism trends, are further shaping the market outlook in Asia-Pacific.

Who are the major players in the Brain Imaging Devices Market?

The following are the leading companies in the brain imaging devices market. These companies collectively hold the largest market share and dictate industry trends.

  • Siemens Healthcare Private Limited
  • GE HealthCare
  • Koninklijke Philips N.V.
  • CANON MEDICAL SYSTEMS CORPORATION
  • Hitachi High-Tech Corporation
  • Fujifilm Holdings Corporation
  • Shimadzu Corporation
  • Esaote SPA
  • Mediso Ltd.
  • Samsung Electronics Co. Ltd
  • MinFound Medical Systems Co., Ltd.
  • Shanghai United Imaging Healthcare Co., Ltd.
  • Voxelgrids Innovations Private Limited
  • MR Solutions
  • PerkinElmer
  • Kindsway Biotech Co., Ltd.
  • SCHILLER
  • Neusoft Medical Systems Co., Ltd.
  • Time Medical Holding
  • Koning Health

How is the competitive landscape shaping the Brain Imaging Devices Market?

The competitive landscape of the brain imaging devices market is characterized by a high degree of market concentration with the presence of leading global medical technology companies, specialized imaging firms, and emerging innovators focusing on AI-driven solutions. Established players such as Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems dominate the market through extensive product portfolios in MRI, CT, and PET imaging, along with strong global distribution networks. At the same time, niche companies and startups are contributing with advancements in portable EEG, MEG, and functional imaging devices, as well as software that enhances diagnostic accuracy through machine learning and data integration. Strategic collaborations, mergers and acquisitions, and partnerships with research institutions are increasingly shaping competition, as firms seek to expand their clinical applications in neurology, oncology, and psychiatry. Moreover, the push towards hybrid imaging systems and non-invasive techniques, combined with growing demand in emerging economies, is intensifying rivalry while opening avenues for technological differentiation and market expansion.

Recent Developmental Activities in the Brain Imaging Devices Market

  • In September 2025, Hyperfine, Inc., a pioneering health technology company that revolutionized brain imaging with the launch of the Swoop(R) system, the first FDA-cleared AI-powered portable MRI for the brain, announced that its Optive AI(TM) software received both CE Marking and UK Conformity Assessment (UKCA) approval.
  • In March 2025, Hyperfine partnered with NVIDIA to enhance the artificial intelligence capabilities of its Swoop Portable MRI system. Recognized as the world's first FDA-approved portable magnetic resonance brain imaging device, Swoop represents a breakthrough in accessible neuroimaging.

Brain Imaging Devices Market Segmentation

  • Brain Imaging Devices by Product Type Exposure
  • Device
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT/SPECT)
  • Positron Emission Tomography (PET)
  • Others
  • Accessories and Consumables
  • Brain Imaging Devices Portability Exposure
  • Staionary
  • Portable
  • Brain Imaging Devices Application Exposure
  • Stroke
  • Brain Tumor
  • Epilepsy
  • Others
  • Brain Imaging Devices End-User Exposure
  • Hospitals
  • Diagnostic Imaging Centers
  • Ambulatory Surgery Centers
  • Others
  • Brain Imaging Devices Geography Exposure
  • North America Brain Imaging Devices Market
  • United States Brain Imaging Devices Market
  • Canada Brain Imaging Devices Market
  • Mexico Brain Imaging Devices Market
  • Europe Brain Imaging Devices Market
  • United Kingdom Brain Imaging Devices Market
  • Germany Brain Imaging Devices Market
  • France Brain Imaging Devices Market
  • Italy Brain Imaging Devices Market
  • Spain Brain Imaging Devices Market
  • Rest of Europe Brain Imaging Devices Market
  • Asia-Pacific Brain Imaging Devices Market
  • China Brain Imaging Devices Market
  • Japan Brain Imaging Devices Market
  • India Brain Imaging Devices Market
  • Australia Brain Imaging Devices Market
  • South Korea Brain Imaging Devices Market
  • Rest of Asia-Pacific Brain Imaging Devices Market
  • Rest of the World Brain Imaging Devices Market
  • South America Brain Imaging Devices Market
  • Middle East Brain Imaging Devices Market
  • Africa Brain Imaging Devices Market

Impact Analysis

AI-Powered Innovations and Applications:

AI-powered innovations are transforming the brain imaging devices market by enhancing diagnostic accuracy, improving workflow efficiency, and enabling new clinical applications. Advanced algorithms integrated into MRI, CT, PET, EEG, and MEG systems are now capable of detecting subtle abnormalities, automating image interpretation, and providing predictive insights into neurological conditions such as stroke, Alzheimer's disease, epilepsy, and brain tumors. These tools reduce diagnostic errors, accelerate decision-making, and support early intervention strategies. Additionally, AI-driven platforms are increasingly being used in tele-radiology and cloud-based imaging solutions, expanding access to high-quality neuroimaging in underserved regions. Beyond diagnostics, AI is also playing a vital role in research and drug development, allowing for precise mapping of brain activity, monitoring treatment outcomes, and supporting clinical trials. By integrating deep learning and machine learning models with brain imaging modalities, the industry is moving toward more personalized and data-driven approaches to neurological care.

U.S. Tariff Impact Analysis on the Brain Imaging Devices Market:

The imposition of U.S. tariffs on medical devices, including components used in brain imaging systems such as MRI, CT, and PET scanners, has had a notable impact on the market. Many brain imaging devices rely on specialized parts, advanced semiconductors, and high-precision electronics that are often sourced from overseas, particularly from regions like China, Japan, and the European Union. Tariffs on these imports increase manufacturing and procurement costs, ultimately driving up the overall price of brain imaging systems. This not only puts pressure on manufacturers to absorb or pass on additional costs but also affects purchasing decisions by hospitals, diagnostic centers, and research institutions, especially smaller facilities with limited budgets. Moreover, higher equipment prices may slow down the adoption of next-generation imaging technologies in the U.S., potentially widening the gap in accessibility between large urban hospitals and smaller or rural healthcare providers. At the same time, these tariffs could encourage domestic innovation and local sourcing strategies, as companies seek to reduce dependency on imported components, thereby reshaping the competitive landscape over the long term.

How This Analysis Helps Clients

  • Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
  • Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
  • Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
  • Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.

Key takeaways from the Brain Imaging Devices market report study

  • Market size analysis for the current brain imaging devices market size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the brain imaging devices market.
  • Various opportunities available for the other competitors in the brain imaging devices market space.
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current brain imaging devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for the brain imaging devices market growth in the future?

Frequently Asked Questions for the Brain Imaging Devices Market

1. What is the growth rate of the brain imaging devices market?

  • The brain imaging devices market is estimated to grow at a CAGR of 5.50% during the forecast period from 2025 to 2032.

2. What is the market for brain imaging devices?

  • The brain imaging devices market was valued at USD 5,091.71 million in 2024, and is expected to reach USD 7,779.85 million by 2032.

3. Which region has the highest share in the brain imaging devices market?

  • The North American brain imaging devices market is a dominant force globally, driven by the high prevalence of neurological disorders, strong R&D investment, advanced healthcare infrastructure, and continuous innovation by leading medical device companies.

4. What are the drivers for the brain imaging devices market?

  • The global brain imaging devices market is driven by the rising prevalence of neurological disorders, technological advancements, especially AI and ML integration, and increasing product development activities by key market players, including innovations in MRI, CT, and PET technologies.

5. Who are the key players operating in the brain imaging devices market?

  • Some of the key market players operating in the brain imaging devices market Siemens Healthcare Private Limited, GE HealthCare, Koninklijke Philips N.V., CANON MEDICAL SYSTEMS CORPORATION, Hitachi High-Tech Corporation, Fujifilm Holdings Corporation, Shimadzu Corporation, Esaote SPA, Mediso Ltd., Samsung Electronics Co. Ltd, MinFound Medical Systems Co., Ltd., Shanghai United Imaging Healthcare Co., Ltd., Voxelgrids Innovations Private Limited, MR Solutions, PerkinElmer, Kindsway Biotech Co., Ltd., SCHILLER, Neusoft Medical Systems Co., Ltd., Time Medical Holding, Koning Health, and Others.

Table of Contents

1. Brain Imaging Devices Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumption

2. Brain Imaging Devices Market Executive Summary

  • 2.1 Market at Glance

3. Brain Imaging Devices Market Key Factors Analysis

  • 3.1 Brain Imaging Devices Market Drivers
    • 3.1.1 The rising prevalence of neurological disorders
    • 3.1.2 Technological advancements such as the integration of AI and ML
    • 3.1.3 Increase in product development activities among the key players
  • 3.2 Brain Imaging Devices Market Restraints and Challenges
    • 3.2.1 High cost of equipment and maintenance
    • 3.2.2 High risk of radiation exposure
  • 3.3 Brain Imaging Devices Market Opportunity
    • 3.3.1 Increase in the use of portable imaging devices and point-of-care diagnostics.

4. Impact Analysis

  • 4.1 AI-Powered Innovations and Applications
  • 4.2 U.S. Tariff Impact Analysis

5. Regulatory Analysis

  • 5.1 The United States
  • 5.2 Europe
  • 5.3 Japan
  • 5.4 China

6. Brain Imaging Devices Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Consumers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. Brain Imaging Devices Market Assessment

  • 7.1 By Product Type
    • 7.1.1 Device
      • 7.1.1.1 Magnetic Resonance Imaging (MRI)
      • 7.1.1.2 Computed Tomography (CT/SPECT)
      • 7.1.1.3 Positron Emission Tomography (PET)
      • 7.1.1.4 Others
    • 7.1.2 Accessories and Consumables
  • 7.2 By Portability
    • 7.2.1 Staionary
    • 7.2.2 Portable
  • 7.3 By Application
    • 7.3.1 Stroke
    • 7.3.2 Brain Tumor
    • 7.3.3 Epilepsy
    • 7.3.4 Others
  • 7.4 By End-User
    • 7.4.1 Hospitals
    • 7.4.2 Diagnostic Imaging Centers
    • 7.4.3 Ambulatory Surgery Centers
    • 7.4.4 Others
  • 7.5 By Geography
    • 7.5.1 North America
      • 7.5.1.1 United States Brain Imaging Devices Market Size in USD million (2022-2032)
      • 7.5.1.2 Canada Brain Imaging Devices Market Size in USD million (2022-2032)
      • 7.5.1.3 Mexico Brain Imaging Devices Market Size in USD million (2022-2032)
    • 7.5.2 Europe
      • 7.5.2.1 France Brain Imaging Devices Market Size in USD million (2022-2032)
      • 7.5.2.2 Germany Brain Imaging Devices Market Size in USD million (2022-2032)
      • 7.5.2.3 United Kingdom Brain Imaging Devices Market Size in USD million (2022-2032)
      • 7.5.2.4 Italy Brain Imaging Devices Market Size in USD million (2022-2032)
      • 7.5.2.5 Spain Brain Imaging Devices Market Size in USD million (2022-2032)
      • 7.5.2.6 Rest of Europe Brain Imaging Devices Market Size in USD million (2022-2032)
    • 7.5.3 Asia-Pacific
      • 7.5.3.1 China Brain Imaging Devices Market Size in USD million (2022-2032)
      • 7.5.3.2 Japan Brain Imaging Devices Market Size in USD million (2022-2032)
      • 7.5.3.3 India Brain Imaging Devices Market Size in USD million (2022-2032)
      • 7.5.3.4 Australia Brain Imaging Devices Market Size in USD million (2022-2032)
      • 7.5.3.5 South Korea Brain Imaging Devices Market Size in USD million (2022-2032)
      • 7.5.3.6 Rest of Asia-Pacific Brain Imaging Devices Market Size in USD million (2022-2032)
    • 7.5.4 Rest of the World (RoW)
      • 7.5.4.1 Middle East Brain Imaging Devices Market Size in USD million (2022-2032)
      • 7.5.4.2 Africa Brain Imaging Devices Market Size in USD million (2022-2032)
      • 7.5.4.3 South America Brain Imaging Devices Market Size In USD Million (2022-2032)

8. Competitive Landscape

9. Startup Funding & Investment Trends

10. Brain Imaging Devices Market Company and Product Profiles

  • 10.1 Siemens Healthcare Private Limited
    • 10.1.1 Company Overview
    • 10.1.2 Company Snapshot
    • 10.1.3 Financial Overview
    • 10.1.4 Product Listing
    • 10.1.5 Entropy
  • 10.2 GE HealthCare
    • 10.2.1 Company Overview
    • 10.2.2 Company Snapshot
    • 10.2.3 Financial Overview
    • 10.2.4 Product Listing
    • 10.2.5 Entropy
  • 10.3 Koninklijke Philips N.V.
    • 10.3.1 Company Overview
    • 10.3.2 Company Snapshot
    • 10.3.3 Financial Overview
    • 10.3.4 Product Listing
    • 10.3.5 Entropy
  • 10.4 CANON MEDICAL SYSTEMS CORPORATION
    • 10.4.1 Company Overview
    • 10.4.2 Company Snapshot
    • 10.4.3 Financial Overview
    • 10.4.4 Product Listing
    • 10.4.5 Entropy
  • 10.5 Hitachi High-Tech Corporation
    • 10.5.1 Company Overview
    • 10.5.2 Company Snapshot
    • 10.5.3 Financial Overview
    • 10.5.4 Product Listing
    • 10.5.5 Entropy
  • 10.6 Fujifilm Holdings Corporation
    • 10.6.1 Company Overview
    • 10.6.2 Company Snapshot
    • 10.6.3 Financial Overview
    • 10.6.4 Product Listing
    • 10.6.5 Entropy
  • 10.7 Shimadzu Corporation
    • 10.7.1 Company Overview
    • 10.7.2 Company Snapshot
    • 10.7.3 Financial Overview
    • 10.7.4 Product Listing
    • 10.7.5 Entropy
  • 10.8 Esaote SPA
    • 10.8.1 Company Overview
    • 10.8.2 Company Snapshot
    • 10.8.3 Financial Overview
    • 10.8.4 Product Listing
    • 10.8.5 Entropy
  • 10.9 Mediso Ltd.
    • 10.9.1 Company Overview
    • 10.9.2 Company Snapshot
    • 10.9.3 Financial Overview
    • 10.9.4 Product Listing
    • 10.9.5 Entropy
  • 10.10 Samsung Electronics Co. Ltd
    • 10.10.1 Company Overview
    • 10.10.2 Company Snapshot
    • 10.10.3 Financial Overview
    • 10.10.4 Product Listing
    • 10.10.5 Entropy
  • 10.11 MinFound Medical Systems Co., Ltd.
    • 10.11.1 Company Overview
    • 10.11.2 Company Snapshot
    • 10.11.3 Financial Overview
    • 10.11.4 Product Listing
    • 10.11.5 Entropy
  • 10.12 Shanghai United Imaging Healthcare Co., Ltd.
    • 10.12.1 Company Overview
    • 10.12.2 Company Snapshot
    • 10.12.3 Financial Overview
    • 10.12.4 Product Listing
    • 10.12.5 Entropy
  • 10.13 Voxelgrids Innovations Private Limited
    • 10.13.1 Company Overview
    • 10.13.2 Company Snapshot
    • 10.13.3 Financial Overview
    • 10.13.4 Product Listing
    • 10.13.5 Entropy
  • 10.14 MR Solutions
    • 10.14.1 Company Overview
    • 10.14.2 Company Snapshot
    • 10.14.3 Financial Overview
    • 10.14.4 Product Listing
    • 10.14.5 Entropy
  • 10.15 PerkinElmer
    • 10.15.1 Company Overview
    • 10.15.2 Company Snapshot
    • 10.15.3 Financial Overview
    • 10.15.4 Product Listing
    • 10.15.5 Entropy
  • 10.16 Kindsway Biotech Co., Ltd.
    • 10.16.1 Company Overview
    • 10.16.2 Company Snapshot
    • 10.16.3 Financial Overview
    • 10.16.4 Product Listing
    • 10.16.5 Entropy
  • 10.17 SCHILLER
    • 10.17.1 Company Overview
    • 10.17.2 Company Snapshot
    • 10.17.3 Financial Overview
    • 10.17.4 Product Listing
    • 10.17.5 Entropy
  • 10.18 Neusoft Medical Systems Co., Ltd.
    • 10.18.1 Company Overview
    • 10.18.2 Company Snapshot
    • 10.18.3 Financial Overview
    • 10.18.4 Product Listing
    • 10.18.5 Entropy
  • 10.19 Time Medical Holding
    • 10.19.1 Company Overview
    • 10.19.2 Company Snapshot
    • 10.19.3 Financial Overview
    • 10.19.4 Product Listing
    • 10.19.5 Entropy
  • 10.20 Koning Health
    • 10.20.1 Company Overview
    • 10.20.2 Company Snapshot
    • 10.20.3 Financial Overview
    • 10.20.4 Product Listing
    • 10.20.5 Entropy

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer & Contact Us

List of Tables

  • Table 1: Brain Imaging Devices Market in Global (2022-2032)
  • Table 2: Brain Imaging Devices Market in Global by Product Type (2022-2032)
  • Table 3: Brain Imaging Devices Market in Global by Potability (2022-2032)
  • Table 4: Brain Imaging Devices Market in Global by Application (2022-2032)
  • Table 5: Brain Imaging Devices Market in Global by End-User (2022-2032)
  • Table 6: Brain Imaging Devices Market in Global by Geography (2022-2032)
  • Table 7: Brain Imaging Devices Market in North America (2022-2032)
  • Table 8: Brain Imaging Devices Market in the United States (2022-2032)
  • Table 9: Brain Imaging Devices Market in Canada (2022-2032)
  • Table 10: Brain Imaging Devices Market in Mexico (2022-2032)
  • Table 11: Brain Imaging Devices Market in Europe (2022-2032)
  • Table 12: Brain Imaging Devices Market in France (2022-2032)
  • Table 13: Brain Imaging Devices Market in Germany (2022-2032)
  • Table 14: Brain Imaging Devices Market in United Kingdom (2022-2032)
  • Table 15: Brain Imaging Devices Market in Italy (2022-2032)
  • Table 16: Brain Imaging Devices Market in Spain (2022-2032)
  • Table 17: Brain Imaging Devices Market in the Rest of Europe (2022-2032)
  • Table 18: Brain Imaging Devices Market in Asia-Pacific (2022-2032)
  • Table 19: Brain Imaging Devices Market in China (2022-2032)
  • Table 20: Brain Imaging Devices Market in Japan (2022-2032)
  • Table 21: Brain Imaging Devices Market in India (2022-2032)
  • Table 22: Brain Imaging Devices Market in Australia (2022-2032)
  • Table 23: Brain Imaging Devices Market in South Korea (2022-2032)
  • Table 24: Brain Imaging Devices Market in Rest of Asia-Pacific (2022-2032)
  • Table 25: Brain Imaging Devices Market in the Rest of the World (2022-2032)
  • Table 26: Brain Imaging Devices Market in the Middle East (2022-2032)
  • Table 27: Brain Imaging Devices Market in Africa (2022-2032)
  • Table 28: Brain Imaging Devices Market in South America (2022-2032)
  • Table 29: Competitive Landscape
  • Table 30: Startup Funding & Investment Trends

List of Figures

  • Figure 1: Brain Imaging Devices Market Drivers
  • Figure 2: Brain Imaging Devices Market Restraints
  • Figure 3: Brain Imaging Devices Market Opportunities
  • Figure 4: AI-Powered Innovations in Brain Imaging Devices Market
  • Figure 5: US Tariff Impact on Brain Imaging Devices Market
  • Figure 6: Regulatory Analysis (US, EU, Japan, China)
  • Figure 7: Porter's Five Forces Analysis
  • Figure 8: Competitive Analysis
  • Figure 9: Brain Imaging Devices Market in Global (2022-2032)
  • Figure 10: Brain Imaging Devices Market in Global by Product Type (2022-2032)
  • Figure 11: Brain Imaging Devices Market in Global by Portability (2022-2032)
  • Figure 12: Brain Imaging Devices Market in Global by Application (2022-2032)
  • Figure 13: Brain Imaging Devices Market in Global by End-User (2022-2032)
  • Figure 14: Brain Imaging Devices Market in Global by Geography (2022-2032)
  • Figure 15: Brain Imaging Devices Market in North America (2022-2032)
  • Figure 16: Brain Imaging Devices Market in the United States (2022-2032)
  • Figure 17: Brain Imaging Devices Market in Canada (2022-2032)
  • Figure 18: Brain Imaging Devices Market in Mexico (2022-2032)
  • Figure 19: Brain Imaging Devices Market in Europe (2022-2032)
  • Figure 20: Brain Imaging Devices Market in France (2022-2032)
  • Figure 21: Brain Imaging Devices Market in Germany (2022-2032)
  • Figure 22: Brain Imaging Devices Market in United Kingdom (2022-2032)
  • Figure 23: Brain Imaging Devices Market in Italy (2022-2032)
  • Figure 24: Brain Imaging Devices Market in Spain (2022-2032)
  • Figure 25: Brain Imaging Devices Market in the Rest of Europe (2022-2032)
  • Figure 26: Brain Imaging Devices Market in Asia-Pacific (2022-2032)
  • Figure 27: Brain Imaging Devices Market in China (2022-2032)
  • Figure 28: Brain Imaging Devices Market in Japan (2022-2032)
  • Figure 29: Brain Imaging Devices Market in India (2022-2032)
  • Figure 30: Brain Imaging Devices Market in Australia (2022-2032)
  • Figure 31: Brain Imaging Devices Market in South Korea (2022-2032)
  • Figure 32: Brain Imaging Devices Market in Rest of Asia-Pacific (2022-2032)
  • Figure 33: Brain Imaging Devices Market in the Rest of the World (2022-2032)
  • Figure 34: Brain Imaging Devices Market in the Middle East (2022-2032)
  • Figure 35: Brain Imaging Devices Market in Africa (2022-2032)
  • Figure 36: Brain Imaging Devices Market in South America (2022-2032)
  • Figure 37: Competitive Landscape
  • Figure 38: Startup Funding & Investment Trends